1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA AAED1 CTRPv2 pan-cancer AAC -0.14 6e-05
mRNA AATK-AS1 CTRPv2 pan-cancer AAC 0.12 0.0004
mRNA ABCC8 CTRPv2 pan-cancer AAC 0.15 1e-06
mRNA ABCD4 CTRPv2 pan-cancer AAC 0.16 7e-07
mRNA ABHD17B CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA ABLIM2 CTRPv2 pan-cancer AAC 0.13 4e-05
mRNA AC003002.6 CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA AC003005.4 CTRPv2 pan-cancer AAC 0.13 2e-05
mRNA AC003006.7 CTRPv2 pan-cancer AAC 0.19 7e-09
mRNA AC004381.6 CTRPv2 pan-cancer AAC 0.15 3e-06
Download CSV